<PAGE>
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement [ ] Confidential, for Use of the
Commission Only (as permitted
by
Rule 14a-6(e)(2))
[X] Definitive Proxy Statement
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to Section 240.14a-11(c) or Section
240.14a-12
Bond Portfolio for Endowments, Inc.
- ------------------------------------------------------------------------------
- -
(Name of Registrant as Specified In Its Charter)
- ------------------------------------------------------------------------------
- -
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[ ] $125 per Exchange Act Rules 0-11(c)(1)(ii), 14a-6(i)(1), 14a-6(i)(2)
or Item 22(a)(2) of Schedule 14A.
[ ] $500 per each party to the controversy pursuant to Exchange Act Rule
14a-6(i)(3).
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
---------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
---------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was determined):
---------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
---------------------------------------------------------------------------
(5) Total fee paid:
---------------------------------------------------------------------------
[X] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration
statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
---------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
---------------------------------------------------------------------------
(3) Filing Party:
---------------------------------------------------------------------------
(4) Date Filed:
---------------------------------------------------------------------------
Notes:
<PAGE>
BOND PORTFOLIO FOR ENDOWMENTS, INC.
Four Embarcadero Center
P.O. Box 7650
San Francisco, California 94120
NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
NOVEMBER 16, 1995
To the Shareholders of Bond Portfolio for Endowments, Inc.:
The Annual Meeting of Shareholders of Bond Portfolio for Endowments, Inc. (the
"fund") will be held at the offices of Capital Research and Management Company,
333 South Hope Street, 50th Floor, Los Angeles, California, on Thursday,
November 16, 1995, at 10:15 a.m., local time, to consider and vote on the
following matters described under the corresponding numbers in the accompanying
Proxy Statement:
(1) election of a board of eight (8) directors;
(2) amendment of Article Sixth of the Certificate of Incorporation to reduce
the authorized capital stock of the fund to 5,000,000 shares;
(3) ratification of the selection by the Board of Directors of Deloitte &
Touche LLP as independent accountants for the fund for the fiscal year ending
July 31, 1996; and
(4) such other matters as may properly come before the meeting.
The Board of Directors has fixed the close of business on September 27, 1995
as the record date for the determination of shareholders entitled to receive
notice of and to vote at the annual meeting.
THE PROPOSED BUSINESS CANNOT BE CONDUCTED AT THE ANNUAL MEETING UNLESS THE
HOLDERS OF A MAJORITY OF THE SHARES OF THE FUND ARE PRESENT IN PERSON OR BY
PROXY. THEREFORE, PLEASE MARK, DATE, SIGN AND RETURN THE ENCLOSED PROXY, WHICH
IS SOLICITED BY THE BOARD OF DIRECTORS. THE PROXY IS REVOCABLE AND WILL NOT
AFFECT YOUR RIGHT TO VOTE IN PERSON IN THE EVENT YOU ATTEND THE MEETING.
By Order of the Board of Directors
Patrick F. Quan
Secretary
San Francisco, California
October 3, 1995
IT IS IMPORTANT THAT YOU MARK, DATE, SIGN, AND
PROMPTLY MAIL THE ENCLOSED PROXY.
PROXY STATEMENT
The enclosed Proxy is solicited by the Board of Directors of the fund in
connection with the Annual Meeting of Shareholders to be held on Thursday,
November 16, 1995. Every Proxy returned in time to be voted at the meeting
will be voted, and, if a specification is made with respect to any proposal,
the Proxy will be voted accordingly. Anyone giving a Proxy may revoke it prior
to its exercise, either by filing with the fund a written notice of revocation,
by delivering a duly executed Proxy bearing a later date, or by attending the
meeting and voting in person.
At the close of business on September 27, 1995, the record date fixed by the
Board of Directors for the determination of shareholders entitled to notice of
and to vote at the meeting, there were outstanding 2,649,293 common shares of
capital stock, $1 par value, the only authorized class of voting securities of
the fund. Each share is entitled to one vote. There is no provision for
cumulative voting. As of August 31, 1995 the shareholders who owned 5% or more
of the fund's outstanding stock were: California Institute of the Arts,
514,168 shares (19.71%); Episcopal Homes Foundation, 172,955 shares (6.63%);
Hospitaller Foundation of California, 140,243 shares (5.38%); St. Mark's School
of Texas, 425,349 shares (16.31%); and San Francisco Opera Association, 152,816
shares (5.86%).
This Proxy Statement was first mailed to shareholders on or about October 3,
1995. The fund's Annual Report for the fiscal year ended July 31, 1995
including financial statements has been mailed to each shareholder entitled to
vote at the meeting. The report is not to be regarded as proxy soliciting
material or as part of this Proxy Statement.
With respect to the election of directors (Item 1), the eight nominees
receiving the highest number of votes shall be deemed to be elected. The vote
required to approve Item 2 is the affirmative vote of the lesser of (a) 67% or
more of all shares present in person or by proxy, provided the holders of more
than 50% of all outstanding voting shares are present or represented by proxy,
or (b) more than 50% of all outstanding voting shares on the record date. The
vote required to approve Item 3 is the affirmative vote of more than 50% of all
outstanding voting shares on the record date.
In the event that sufficient votes are not received by the meeting date, a
person named as proxy may propose one or more adjournments of the meeting for a
period or periods of not more than 30 days in the aggregate to permit further
solicitation of proxies. The persons named as proxies may vote all Proxies in
favor of such adjournment. Signed but unmarked Proxies will be voted for the
below nominated Directors and in favor of all proposals. Proxies marked as
abstaining from voting on one or more proposals are treated as being present at
the meeting for purposes of obtaining the quorum necessary to hold the meeting,
but are not counted as part of the vote necessary to approve the proposal(s).
1. ELECTION OF DIRECTORS
Eight directors are to be elected at the meeting to hold office until the next
annual meeting of shareholders and until their successors are elected and
qualified. All of the nominees were elected by the shareholders at a meeting
held November 17, 1994. The directors were nominated for re-election at a
meeting of the Board held August 11, 1995. Each of the nominees has agreed to
serve as a director if re-elected. The Certificate of Incorporation provides
that each director, except for the Chairman of the Board or the President,
shall be a designated representative of at least one charitable institution
which is a shareholder of the fund or of Endowments, Inc. If, due to present
unforeseen circumstances, any nominee should not be available for election, the
persons named as proxies will vote the signed but unmarked Proxies and those
marked for the nominated directors for such other nominee as the present
directors shall recommend. The table below sets forth certain information
regarding the nominees.
<TABLE>
<CAPTION>
Name of Nominee Current Principal Year First Memberships on
(Position with Occupation and Elected a Boards of Other
Fund) Principal Employment Director Registered Investment
and Age During Past Five Years # Companies and Publicly
Held Companies
<S> <C> <C> <C>
* Robert B. Egelston Senior Partner, The 1989 Emerging Markets Growth
(Chairman of the Capital Group Fund
Board) Partners, L.P.; former Endowments
64 Chairman of the Board, The New Economy Fund
The Capital Group SMALLCAP World Fund
Companies, Inc.
+@**Frank L. Ellsworth President, Independent 1992 Anchor Pathway Fund
(Director) Colleges of Southern Endowments
52 California; former The Polaris Trust
President, Pitzer College.
Designated Representative:
Independent Colleges of
Southern California.
+@Steven D. Lavine President, California 1994 Endowments
(Director) Institute of the Arts.
48 Designated Representative:
California Institute of
the Arts.
+@Patricia A. McBride Chief Financial Officer, 1988 Endowments
(Director) Kevin L. McBride,
52 D.D.S., Inc.
Designated Representative:
St. Mark's School of
Texas.
+@John R. Metcalf Private investor; former 1971 Endowments
(Director) Vice President,
79 Alexander and Alexander.
Designated Representative:
Alpine Winter Foundation.
+@Charles R. Redmond Chairman, Pfaffinger 1988 Endowments
(Director) Foundation, and President
69 and Chief Executive Officer,
Times Mirror Foundation;
former Executive Vice
President and Member of the
Management Committee, The
Times Mirror Company.
Designated Representative:
Loyola Marymount University.
* Thomas E. Terry Consultant. Former Vice 1994 American Variable Insurance Series
(President and President and Secretary, Endowments
(Director) Capital Research and
57 Management Company.
Designated Representative:
Citizens' Scholarship
Foundation of America.
+@Robert C. Ziebarth Management Consultant, 1993 Endowments
(Director) Ziebarth Company.
59 Designated Representative:
Foundation for Reproductive
Research & Education.
</TABLE>
______________________
# Corporate positions, in some instances, may have changed during the period.
* Is considered an "interested person" of the fund within the meaning of the
Investment Company Act of 1940 (the "1940 Act"), on the basis of his
affiliation with Capital Research and Management Company (the "Investment
Adviser").
+ The fund has an Audit Committee comprised of the above-designated directors.
The function of the Committee includes such specific matters as recommending
the independent accountant to the Board of Directors, reviewing the audit plan
and results of audits and considering matters deemed appropriate by the Board
of Directors and/or the Committee.
@ The fund has a Contracts Committee comprised of the above-designated
directors who are not considered to be "interested persons" of the fund within
the meaning of the 1940 Act. The Committee's function is to request, review
and consider the information deemed necessary to evaluate the terms of the
investment advisory agreement that the fund proposes to enter into, renew or
continue prior to voting thereon, and to make its recommendations to the full
Board of Directors on these matters.
** Mr. Ellsworth serves as a director or trustee on the boards of a total of
three funds, which are managed by Capital Research and Management Company.
Only Anchor Pathway Fund pays a directors fee. His total compensation from
that fund for the 12 months through July 31, 1995 was $13,000.
Shares of the fund may be purchased only by institutional investors exempt
from taxation under Section 501(c)(3) of the Internal Revenue Code. Therefore,
none of the directors owns any shares of the fund. Furthermore, the fund pays
no salaries or other compensation to its directors.
There were four Board of Directors, one Contracts Committee, and two Audit
Committee meetings in the fiscal year 1995. Each of the nominees, except Mr.
Lavine, attended at least 75% of all meetings of the Board and of the
committees of which he or she was a member.
OTHER EXECUTIVE OFFICERS
<TABLE>
<CAPTION>
<S> <C> <C>
Name Principal Occupation Officer
(Position with Fund) for Last Five Years /1/ Continuously
and Age Since/2/
Abner D. Goldstine Senior Vice President and Director, 1995
(Senior Vice President) Capital Research and Management
65 Company.
George A. Miller Senior Vice President and Director, 1995
(Senior Vice President) Capital Research and Management
59 Company.
Robert G. O'Donnell Senior Vice President and Director, 1995
(Senior Vice President) Capital Research and Management
51 Company.
Steven N. Kearsley Vice President and 1975
(Vice President and Treasurer, Capital
Treasurer) Research and Management
54 Company.
Patrick F. Quan Vice President - Fund 1986
(Secretary) Business Management Group,
37 Capital Research and
Management Company.
</TABLE>
__________________
/1/ The occupation shown reflects the principal employment of each individual
during the past five years. Corporate positions, in some instances, may have
changed during the period.
/2/ Officers are elected to hold office until their respective successors are
elected, or until they resign or are removed.
No officers, directors, or employees of Capital Research and Management
Company, its parent, or its subsidiaries received any remuneration directly
from the fund.
2. REDUCTION OF AUTHORIZED CAPITAL STOCK
The fund has authorized capitalization of 10,000,000 shares of $1.00 par value
common capital stock. It is proposed that the authorized capitalization be
reduced to 5,000,000 shares of $1.00 par value common capital stock.
For purpose of calculating franchise taxes for the State of Delaware, where
the fund is incorporated, the total number of shares authorized by the fund, as
opposed to the shares outstanding, is used in determining the tax owed. When
fund shares are redeemed, they are added back to the number of shares available
for sale. Capital Research and Management Company, as investment adviser to the
fund, feels that 5,000,000 shares would provide sufficient authorized shares to
meet anticipated sales.
The directors believe that it is advisable to reduce the authorized capital
stock of the fund at this time in order to realize savings attributable to a
reduction in franchise taxes paid by the fund to the State of Delaware. The
Investment Adviser believes that the fund and its shareholders will benefit
from this savings, and the fund can easily amend its Certificate of
Incorporation to increase the number of shares authorized when share sales
warrant such an increase. As of September 27, 1995, there were 2,649,293 shares
of the fund outstanding.
Such a reduction of the authorized capital stock may be accomplished by
appropriate amendment of the Certificate of Incorporation of the fund. The
Board of Directors has adopted a resolution to effect this amendment, and in
order for such an amendment to become effective under Delaware Corporation Law,
a similar resolution must be adopted by the shareholders.
The proposed amendment will not affect the par value, nature, or rights of the
fund's capital shares now outstanding or shares which may subsequently be
issued, nor will it affect the method by which the fund's shares are sold and
issued.
THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE IN FAVOR OF THE AMENDMENT OF
ARTICLE SIXTH OF THE CERTIFICATE OF INCORPORATION TO REDUCE THE AUTHORIZED
CAPITAL STOCK OF THE FUND TO 5,000,000 SHARES.
3. RATIFICATION OF THE SELECTION BY THE BOARD OF DIRECTORS OF DELOITTE &
TOUCHE LLP AS INDEPENDENT ACCOUNTANTS FOR THE FISCAL YEAR 1996
Shareholders are requested to ratify the selection by the Board of Directors
(including a majority of directors who are not "interested persons" of the fund
as that term is defined in the 1940 Act) of the firm of Deloitte & Touche LLP
as independent accountants for the fund for the fiscal year 1996. In addition
to the normal audit services, Deloitte & Touche LLP will provide services in
connection with the preparation and review of federal and state tax returns for
the fund. Deloitte & Touche LLP has served as the fund's independent
accountants since February 13, 1991 and has advised the fund that it has no
material direct or indirect financial interest in the fund or its affiliates.
No representative of the firm of Deloitte & Touche LLP is expected to be
available to answer questions or attend the meeting of shareholders.
THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE FOR RATIFICATION OF THEIR
SELECTION OF DELOITTE & TOUCHE LLP.
OTHER MATTERS
Neither the persons named in the enclosed Proxy nor the Board of Directors are
aware of any matters that will be presented for action at the meeting other
than matters set forth herein. Should any other matters properly requiring a
vote of shareholders arise, the Proxy in the accompanying form will confer upon
the person or persons entitled to vote the shares represented by such Proxy
discretionary authority to vote the shares in respect of any such matters in
accordance with their best judgment in the interest of the fund and its
shareholders.
SHAREHOLDER PROPOSALS
Notice is hereby given that any shareholder proposals for inclusion in the
proxy solicitation materials for the next annual meeting, presently scheduled
for November 1996, must be received by the fund at its principal executive
offices, Four Embarcadero Center, Suite 1800, San Francisco, CA 94111, not less
than 120 days in advance of the first anniversary of the date of this Proxy
Statement. Any such proposals must comply with the requirements of Rule 14a-8
promulgated under the Securities Exchange Act of 1934.
GENERAL INFORMATION
Capital Research and Management Company is the investment adviser to the fund
and is located at 333 South Hope Street, Los Angeles, CA 90071 and 135 South
State College Boulevard, Brea, CA 92621.
The cost of solicitation of the enclosed Proxies will be borne by the fund.
If necessary to ensure satisfactory representation at the meeting, the officers
of the fund may solicit proxies to a limited extent by telephone or telecopier.
Any such additional solicitation would be undertaken without cost to the fund,
except actual out-of-pocket communication charges which are estimated not to
exceed $1,000. ALL SHAREHOLDERS ARE URGED TO MARK, DATE, SIGN AND RETURN THE
PROXY CARD IN THE ENCLOSED ENVELOPE, WHICH REQUIRES NO POSTAGE IF MAILED IN THE
UNITED STATES.
A COPY OF THE FUND'S MOST RECENT ANNUAL REPORT MAY BE OBTAINED, WITHOUT
CHARGE, BY WRITING TO THE SECRETARY OF THE FUND AT FOUR EMBARCADERO CENTER,
SUITE 1800, SAN FRANCISCO, CA 94111, OR BY TELEPHONING 415/421-9360. THESE
REQUESTS WILL BE HONORED WITHIN THREE BUSINESS DAYS OF RECEIPT.
By Order of the Board of Directors
Patrick F. Quan
Secretary
October 3, 1995
<PAGE>
PROXY
BOND PORTFOLIO FOR ENDOWMENTS, INC.
PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF THE
FUND FOR THE ANNUAL MEETING
OF SHAREHOLDERS TO BE HELD NOVEMBER 16, 1995
The undersigned hereby appoints Thomas E. Terry and Patrick F. Quan as lawful
agents and proxies, each with full power to appoint a substitute to represent
the undersigned at the aforesaid Annual Meeting of Shareholders to be held at
the offices of Capital Research and Management Company, 333 South Hope Street,
50th Floor, Los Angeles, California, on Thursday, November 16, 1995, at 10:15
a.m., on all matters coming before said meeting.
1. ELECTION OF DIRECTORS
Nominees: Robert B. Egelston, Frank L. Ellsworth, Steven D. Lavine, Patricia
A. McBride, John R. Metcalf, Charles R. Redmond, Thomas E. Terry,
and Robert C. Ziebarth
[ ] VOTE FOR all nominees listed above, except vote withheld from the
following nominees (if any):
-----------------------------------------------------------------
-----------------------------------------------------------------
OR
[ ] VOTE WITHHELD from all nominees.
2. AMENDMENT OF ARTICLE SIXTH OF THE CERTIFICATE OF INCORPORATION TO REDUCE THE
AUTHORIZED CAPITAL STOCK OF THE FUND TO 5,000,000 SHARES
[ ] FOR [ ] AGAINST [ ] ABSTAIN
3. RATIFICATION OF SELECTION OF DELOITTE & TOUCHE LLP AS INDEPENDENT
ACCOUNTANTS
[ ] FOR [ ] AGAINST [ ] ABSTAIN
4. In their discretion, upon other matters as may properly come before the
meeting.
THIS PROXY WHEN PROPERLY EXECUTED WILL BE VOTED IN THE MANNER DIRECTED HEREIN
BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS GIVEN, THIS PROXY WILL BE
VOTED FOR THE NOMINEES LISTED IN ITEM 1 AND FOR ITEMS 2 AND 3.
__________, 1995 __________________________________________
(Date) (Please sign exactly as name appears below)
SHAREHOLDER: {bendi shareholder}
------------------------------
SHARES HELD SEPTEMBER 27, 1995: {shares}
------------------------------
